These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 22980520)

  • 1. Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE.
    Benhamou PY; Catargi B; Delenne B; Guerci B; Hanaire H; Jeandidier N; Leroy R; Meyer L; Penfornis A; Radermecker RP; Renard E; Baillot-Rudoni S; Riveline JP; Schaepelynck P; Sola-Gazagnes A; Sulmont V; Tubiana-Rufi N; Durain D; Mantovani I; Sola-Gazagnes A; Riveline JP; ; ;
    Diabetes Metab; 2012 Jul; 38 Suppl 4():S67-83. PubMed ID: 22980520
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergent technologies applied to diabetes: what do we need to integrate continuous glucose monitoring into daily practice? Where the long-term use of continuous glucose monitoring stands in 2011.
    Sola-Gazagnes A; Vigeral C
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S65-70. PubMed ID: 22208713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time glucose monitoring.
    Ramchandani N; Saadon Y; Jornsay D
    Am J Nurs; 2010 Apr; 110(4):60-3. PubMed ID: 20335693
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous glucose monitoring: current clinical use.
    Kim HS; Shin JA; Chang JS; Cho JH; Son HY; Yoon KH
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():73-8. PubMed ID: 23280870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.
    Logtenberg SJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Diabetes Technol Ther; 2009 May; 11(5):293-9. PubMed ID: 19425877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pascal's wager: combining continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Kerr D; Olateju T
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S43-50. PubMed ID: 20515306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database.
    Welsh JB; Kannard B; Nogueira K; Kaufman FR; Shah R
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():413-6. PubMed ID: 20877255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstrations and discussions of continuous glucose monitors.
    Bode BW
    Diabetes Technol Ther; 2005 Oct; 7(5):805-8. PubMed ID: 16241888
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges for outpatient closed loop studies: how to assess efficacy.
    Beck RW; Calhoun P; Kollman C
    Diabetes Technol Ther; 2013 Jan; 15(1):1-3. PubMed ID: 23297669
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors.
    Mitre TM; Legault L; Rabasa-Lhoret R; Haidar A
    Diabetes Technol Ther; 2014 May; 16(5):326-7. PubMed ID: 24447013
    [No Abstract]   [Full Text] [Related]  

  • 12. Using the continuous glucose monitoring system to improve the management of type 1 diabetes.
    Bode BW; Hirsch IB
    Diabetes Technol Ther; 2000; 2 Suppl 1():S43-8. PubMed ID: 11469631
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Mitre et al.: "analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors".
    Hovorka R; Nodale M
    Diabetes Technol Ther; 2014 May; 16(5):328-9. PubMed ID: 24690134
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients.
    Ryan MT; Savarese VW; Hipszer B; Dizdarevic I; Joseph M; Shively N; Joseph JI
    Diabetes Technol Ther; 2009 Nov; 11(11):745-7. PubMed ID: 19905892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? ].
    Renard E
    Diabetes Metab; 2003 Apr; 29(2 Pt 2):S54-62. PubMed ID: 12746628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: how schools can integrate technology.
    Bratina N; Battelino T
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():417-21. PubMed ID: 20877256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.
    Jungheim K; Wientjes KJ; Heinemann L; Lodwig V; Koschinsky T; Schoonen AJ;
    Diabetes Care; 2001 Sep; 24(9):1696-7. PubMed ID: 11522729
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose concentration can be predicted ahead in time from continuous glucose monitoring sensor time-series.
    Sparacino G; Zanderigo F; Corazza S; Maran A; Facchinetti A; Cobelli C
    IEEE Trans Biomed Eng; 2007 May; 54(5):931-7. PubMed ID: 17518291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of the continuous glucose monitoring system.
    Bode BW
    Diabetes Technol Ther; 2000; 2 Suppl 1():S35-41. PubMed ID: 11469630
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glucose sensors in tissue, glucose monitoring and controlled insulin administration].
    Pfeiffer EF
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():12-5. PubMed ID: 8839105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.